Journals / Journal of Health Sciences and Medicine / 2026 / Volume: 3 Issue: 1

The prevalence of HHV-6 and variant type in HIV positive patients

HIV pozitif hastalarda HHV-6 prevalansı ve varyant tiplerinin belirlenmesi

Gülnur Tarhan(Adıyaman Üniversitesi Tıp Fakültesi, Tıbbi Mikrobiyoloji Anabilim Dalı, Adıyaman)0000-0002-1019-0798
Neziha Yılmaz(Yozgat Bozok Üniversitesi Tıp Fakültesi, Tıbbi Mikrobiyoloji Anabilim Dalı,Yozgat)0000-0001-9027-079X
Salih Cesur(Ankara Eğitim ve Araştırma Hastanesi, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Kliniği, Ankara)
Pages
—
Publication Date
2020-01-15
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Overall, the positivity rate was 36.3% (28/77).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study was to determine the frequency of HHV-6 DNA in patients with HIV positive infection and HHV-6 variant type (variant A or variant B) in patients with HHV-6 DNA positive Material and Method: Twenty HIV-positive patients and 57 HIV negative healthy subjects were included in the study.
📊
Key Findings & Data:HHV-6 DNA was investigated by polymerase chain reaction (PCR) in the patient and control groups.
💡
Conclusion & Impact:Overall, the positivity rate was 36.3% (28/77).
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:HIV · HHV-6 · varyant A

Abstract

Objective: The aim of this study was to determine the frequency of HHV-6 DNA in patients with HIV positive infection and HHV-6 variant type (variant A or variant B) in patients with HHV-6 DNA positive Material and Method: Twenty HIV-positive patients and 57 HIV negative healthy subjects were included in the study. HHV-6 DNA was investigated by polymerase chain reaction (PCR) in the patient and control groups. In cases with HHV-6 DNA positive, HHV-6 variant was investigated with restriction fragment length polymorphism (RFLP). Statistical analysis was performed using SPSS program, p≤0.05 was considered statistically significant. Results: HHV-6 DNA positivity was found to be 45% (9/20) in HIV positive patients and 33.3% (19/57) in HIV negative patients. Overall, the positivity rate was 36.3% (28/77). HHV-6 variant B was detected in HIV positive patients, but variant A was not. Conclusion: We believe that further clinical studies involving more cases are needed to determine the importance of HHV-6 seropositivity and variant types in HIV positive patients.

Özet

Amaç: Bu çalışmanın amacı HIV enfeksiyonu pozitif saptanan hastalarda HHV-6 DNA sıklığının, HHV-6 DNA’sı pozitif saptanan olgularda ise HHV-6 varyant türünün (varyant A veya varyant B) belirlenmesiydi. Gereç ve Yöntem: Çalışmaya 20 HIV pozitif hasta ile 57 HIV negatif sağlıklı birey dahil edildi. Hasta ve kontrol grubunda HHV-6 DNA’sı polimeraz zincir reaksiyonu (PZR) ile araştırıldı. HHV-6 DNA pozitif saptanan olgularda HHV-6 varyant türü restriksiyon parça uzunluğu polimorfizmi (restriction fragment lenght polymorphisim: RFLP) ile araştırıldı. İstatistiksel değerlendirme SPSS programında yapıldı, p≤0.05 istatistiksel olarak anlamlı kabul edildi. Bulgular: HIV pozitif hastalarda HHV-6 DNA pozitifliği %45 (9/20), HIV negatiflerde ise %33,3 (19/57) olarak belirlendi. Toplamda pozitiflik oranı %36,3 (28/77) idi. HIV pozitif hastalarda HHV-6 varyant B saptanırken, varyant A saptanmadı. Sonuç: HIV pozitif hastalarda HHV-6 seropozitifliği ve varyant tiplerinin öneminin belirlenmesi için daha fazla sayıda olgu içeren başka klinik çalışmalara gereksinim olduğu görüşündeyiz.

🔖

Cite This Article

Tarhan, G., Yılmaz, N. (2020). The prevalence of HHV-6 and variant type in HIV positive patients. Journal of Health Sciences and Medicine, Volume: 3 Issue: 1. https://doi.org/10.32322/jhsm.605654

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Braun DK, Dominguez G, Pellet PE. Human Herpesvirus-6. Clin Mic Rev 1997; 10: 521-67.
  2. Dolcetti R, Luca DD, Mİrandola P, et al. Frequent detection of Human Herpesvirus- 6 DNA in HIV associated lymphoadenopathy. Lancet 1994; 344: 543.
  3. Fox J, Briggs M, Tedder RS. Antibody to human herpesvirus 6 in HIV-1 positive and negative homosexual men. Lancet1988; ii, 396-7.
  4. Spira TJ, Bozeman LH, Sanderlin KC, et al. Lack of correlation between human herpesvirus-6 infection and the course of human immunodeficiency virus infection. J Infect Dis 1989; 161: 567-70.
  5. Corbellino M, Lusso P, Gallo RC. Disseminated human herpesvirus 6 infection in AIDS. Lancet 1993; 342: 1242.
  6. Lindquester GJ, Inoue N, Allen RD, et al. Restriction endonuclease mapping and molecular cloning of the Human Herpesvirus 6 variant B strain Z29 genome. Arch Virol1996; 141: 367-79.
  7. Aubin JT, Collandre H, Candotti D, et al. Several groups among human herpesvirus 6 strains can be distinguished by southernblotting and polymerase chain reaction. J Clin Microbiol 1991; 29, 367-72.
  8. Kositanont U, Wasi C, Wanprapar N, et al. Primary infection of human herpesvirus 6 in children with infection of human immunodeficiency virus type 1. J Infect Dis 1990; 180: 50-5.
  9. Munawwar A, Singh S. Human herpesviruses as copathogens of HIV infection, Their role in HIV transmission, and disease progression. J Lab Physicians 2016; 8: 5-18.
  10. Contreras A, Mardirossian A, Slots J. Herpesviruses in HIV-periodontitis. J Clin Periodontol 2001; 28: 96-102.
  11. Leach CT, Pollock BH, McClain KL, Parmley RT, Murphy SB, Jenson HB. Human herpesvirus 6 and cytomegalovirus infections in children with human immunodeficiency virus infection and cancer. Pediatr Infect Dis J 2002;21: 125-32.
  12. Karlı B, Önel M, Eraksoy H, Ağaçfidan A. İstanbul'da anti-HIV-1 pozitif hastalarda HHV-8 prevalansının araştırılması. Mikrobiyol Bul 2013; 47: 493-9
  13. Leach CT, Pollock BH, McClain KL, Parmley RT, Murphy SB, Jenson HB. Human herpesvirus 6 and cytomegalovirus infections in children with human immunodeficiency virus infection and cancer. Pediatr Infect Dis J 2002;21: 125-32.